Literature DB >> 16425138

Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein.

Jun Lu1, Ning Zhi, Susan Wong, Kevin E Brown.   

Abstract

Parvovirus B19 infection in adults is often associated with acute symmetrical polyarthropathy, but the mechanism is unknown. Recently, a secreted phospholipase A(2) (sPLA(2)) motif was identified in the VP1-unique region (VP1u) of the B19 minor capsid protein. To investigate the role of this motif, we expressed VP1u with and without point mutations in the critical amino acids of sPLA(2). Although high concentrations of B19 did not infect human fibroblast-like synoviocytes (HFLSs), there was a >3-fold increase in synoviocyte migration that could be blocked by phospholipase inhibitors. Recombinant proteins with intact VP1u demonstrated sPLA(2) activity and induced cell migration, whereas proteins with mutated VP1u were nonfunctional in both assays. The incubation of HFLSs with proteins that had intact VP1u, but not with proteins with mutated VP1u, increased the production of prostaglandin E(2) >100-fold. Expression of cyclooxygenase (COX)-2 mRNA transcripts, as determined by real-time reverse-transcription polymerase chain reaction, and COX-2 protein expression were both significantly increased after incubation with protein that had intact VP1u. Proteins with VP1u in noninfectious B19 may participate in the inflammatory response in the synovial compartment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16425138     DOI: 10.1086/499599

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity.

Authors:  Ning Zhi; Ian P Mills; Jun Lu; Susan Wong; Claudia Filippone; Kevin E Brown
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

2.  Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.

Authors:  Anna Ekman; Kati Hokynar; Laura Kakkola; Kalle Kantola; Lea Hedman; Heidi Bondén; Matthias Gessner; Claudia Aberham; Päivi Norja; Simo Miettinen; Klaus Hedman; Maria Söderlund-Venermo
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

3.  Visualization of the externalized VP2 N termini of infectious human parvovirus B19.

Authors:  Bärbel Kaufmann; Paul R Chipman; Victor A Kostyuchenko; Susanne Modrow; Michael G Rossmann
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

4.  Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study.

Authors:  Peter A C Maple; Lea Hedman; Pravesh Dhanilall; Kalle Kantola; Visa Nurmi; Maria Söderlund-Venermo; Kevin E Brown; Klaus Hedman
Journal:  J Clin Microbiol       Date:  2014-01-08       Impact factor: 5.948

5.  Conformational changes in the VP1-unique region of native human parvovirus B19 lead to exposure of internal sequences that play a role in virus neutralization and infectivity.

Authors:  Carlos Ros; Marco Gerber; Christoph Kempf
Journal:  J Virol       Date:  2006-10-04       Impact factor: 5.103

Review 6.  Evolutionary aspects of Parvovirus B-19V associated diseases and their pathogenesis patterns with an emphasis on vaccine development.

Authors:  Piyanki Das; Koustav Chatterjee; Nabanita Roy Chattopadhyay; Tathagata Choudhuri
Journal:  Virusdisease       Date:  2019-03-26

7.  Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening.

Authors:  J Michael Soucie; Christine De Staercke; Paul E Monahan; Michael Recht; Meera B Chitlur; Ralph Gruppo; W Craig Hooper; Craig Kessler; Roshni Kulkarni; Marilyn J Manco-Johnson; Jerry Powell; Meredith Pyle; Brenda Riske; Hernan Sabio; Sean Trimble
Journal:  Transfusion       Date:  2012-09-24       Impact factor: 3.157

8.  Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q.

Authors:  Kristina von Kietzell; Tanja Pozzuto; Regine Heilbronn; Tobias Grössl; Henry Fechner; Stefan Weger
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

9.  The determinants for the enzyme activity of human parvovirus B19 phospholipase A2 (PLA2) and its influence on cultured cells.

Authors:  Xuefeng Deng; Yanming Dong; Qianhui Yi; Yu Huang; Dan Zhao; Yongbo Yang; Peter Tijssen; Jianming Qiu; Kaiyu Liu; Yi Li
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

10.  Effects of human parvovirus B19 VP1 unique region protein on macrophage responses.

Authors:  Bor-Show Tzang; Chun-Ching Chiu; Chun-Chou Tsai; Yi-Ju Lee; I-Jung Lu; Jing-Yu Shi; Tsai-Ching Hsu
Journal:  J Biomed Sci       Date:  2009-01-24       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.